Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome
Elaine Holmes, Julien Wist, Reika Masuda, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 6, pp. 3315-3329
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2751
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 173
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 152
Biomarkers in long COVID-19: A systematic review
Yun‐Ju Lai, Shou-Hou Liu, Sumatchara Manachevakul, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 146
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi, Pilar Alcaide, Folkert W. Asselbergs, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 336-356
Open Access | Times Cited: 127
Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study
M. Maamar, Arancha Artime, Emilio Rodrigo, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 6, pp. 901-909
Open Access | Times Cited: 122
Long COVID: An inevitable sequela of SARS-CoV-2 infection
Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 1, pp. 1-9
Open Access | Times Cited: 104
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 63
The plasma metabolome of long COVID patients two years after infection
Yamilé López‐Hernández, Joel Monárrez‐Espino, David Alejandro García López, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Tihamér Molnár, Andrea Lehoczki, Mónika Fekete, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 5267-5286
Open Access | Times Cited: 27
Long‐term side effects and lingering symptoms post COVID‐19 recovery
Mohammad Zarei, Deepanwita Bose, Masoud Nouri‐Vaskeh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 70
Symptoms and signs of long COVID: A rapid review and meta-analysis
Quin Healey, Aziz Sheikh, Luke Daines, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 66
Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
Matthew J. McConnell, Reiichiro Kondo, Nao Kawaguchi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 2, pp. 255-269
Open Access | Times Cited: 57
Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity
Aurélie Fischer, Lu Zhang, Abir Elbéji, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 44
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism
Anushri Umesh, Kumar Pranay, Ramesh C. Pandey, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1053-1066
Open Access | Times Cited: 40
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
Hélène Ruffieux, Aimee L. Hanson, Samantha Lodge, et al.
Nature Immunology (2023) Vol. 24, Iss. 2, pp. 349-358
Open Access | Times Cited: 33
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
The kynurenine pathway relates to post‐acuteCOVID‐19 objective cognitive impairment andPASC
Lucette A. Cysique, David Jakabek, Sophia G. Bracken, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 8, pp. 1338-1352
Open Access | Times Cited: 28
Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients
Georgy Berezhnoy, Rosi Bissinger, Anna Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
Nawar Diar Bakerly, Nikki Smith, Julie Darbyshire, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 4, pp. 473-473
Open Access | Times Cited: 11
How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
Don L. Goldenberg
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152455-152455
Closed Access | Times Cited: 9
Mast cell activation is associated with post‐acute COVID‐19 syndrome
Joshua B. Wechsler, Melina Butuci, Alan Wong, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1288-1291
Open Access | Times Cited: 52
Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts
Reika Masuda, Samantha Lodge, Philipp Nitschke, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 8, pp. 4139-4152
Closed Access | Times Cited: 43
Uneven metabolic and lipidomic profiles in recovered COVID‐19 patients as investigated by plasma NMR metabolomics
Maider Bizkarguenaga, Chiara Bruzzone, Rubén Gil‐Redondo, et al.
NMR in Biomedicine (2021) Vol. 35, Iss. 2
Open Access | Times Cited: 42
Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning
Vincent R. Richard, Claudia Gaither, Robert Popp, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 10, pp. 100277-100277
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top